Timing of multikinase inhibitor initiation in differentiated thyroid cancer

There are limited treatment options for patients with radioactive iodine refractory, progressive differentiated thyroid cancer. Although there is consensus that multikinase inhibitor therapy should be considered in patients with progressive disease with considerable tumor load or symptomatic disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Brose, Marcia S, Smit, Johannes, Lin, Chia-Chi, Pitoia, Fabian, Fellous, Marc, DeSanctis, Yoriko, Schlumberger, Martin, Tori, Masayuki, Sugitani, Iwao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446590/
https://www.ncbi.nlm.nih.gov/pubmed/28270435
http://dx.doi.org/10.1530/ERC-17-0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446590/
https://www.ncbi.nlm.nih.gov/pubmed/28270435
http://dx.doi.org/10.1530/ERC-17-0016

Ejemplares similares